Research and Markets: Global Brain Cancer Drug Pipeline Capsule - 2012 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/nz39nc/global_brain) has announced the addition of the "Global Brain Cancer Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Brain Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Brain Cancer market. It covers active Brain Cancer pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered:

1. Brain Cancer - Disease Overview

2. Brain Cancer Pipeline Overview

3. Brain Cancer Phase 3 Clinical Trial Pipeline Insights

4. Brain Cancer Phase 2 Clinical Trial Pipeline Insights

5. Brain Cancer Phase 1 Clinical Trial Pipeline Insights

6. Brain Cancer Preclinical Research Pipeline Insights

7. Brain Cancer Discovery Stage Pipeline Insights

8. Brain Cancer Drug Development Activities - Geographic Landscape

8.1. Brain Cancer R&D Activities in North America

8.2. Brain Cancer R&D Activities in Europe

9. Brain Cancer Pipeline - Licensing Activities

Table 1. Brain Cancer Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Brain Cancer Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Brain Cancer Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Brain Cancer Pipeline Molecules - Preclinical Research

Table 5. Brain Cancer Pipeline Molecules - Drug Discovery

Table 6. Brain Cancer R&D Activities by Geography

Table 7. Brain Cancer Pipeline Molecules - North America

Table 8. Brain Cancer Pipeline Molecules - Europe

Table 9. Brain Cancer Pipeline - Licensing Activities

Figure 1. Brain Cancer Pipeline Molecules by R&D Stage

Figure 2. Brain Cancer R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/nz39nc/global_brain

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals